News

Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor–Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies The ...
Mesoblast (MESO) partners with Blood and Marrow Transplant Clinical Trials Network to develop a pivotal study on its lead candidate, Ryoncil, for acute graft versus host disease. The stock rises 11%.
Anne Palmer, a CTN rider, falls into the 11% that ride more than 10 miles. She disagrees with Clupper and said her fare increase will be drastic. Palmer lives outside Fort Wayne city limits and ...
To rule out MI among patients presenting to the emergency department with chest pain, newer, more rapid European Society of Cardiology (ESC) algorithms for high-sensitivity cardiac troponin ...
CTN has been operating several older UHF DTV transmitters that were in need of replacement and inked a contract with Comark to replace the six systems with Parallax transmitters. All the new ...